|1.||Brown, D: 2 articles (11/2004 - 09/2004)|
|2.||Gruppo, R A: 2 articles (11/2004 - 09/2004)|
|3.||Wilkes, M M: 2 articles (11/2004 - 09/2004)|
|4.||Navickis, R J: 2 articles (11/2004 - 09/2004)|
|5.||Talks, K: 1 article (03/2015)|
|6.||Williams, M: 1 article (03/2015)|
|7.||Hart, D P: 1 article (03/2015)|
|8.||Hay, C R M: 1 article (03/2015)|
|9.||Chalmers, E A: 1 article (03/2015)|
|10.||Liesner, R: 1 article (03/2015)|
|1.||Hemophilia A (Haemophilia)
09/01/2003 - "Successful use of B-domain deleted factor VIII for resection of pituitary adenoma in a paediatric patient with severe haemophilia A."
04/01/2004 - "In the first gene therapy trial for hemophilia A, a non-viral approach was being explored for patients with severe hemophilia A using ex vivo transfected dermal fibroblast expressing B-domain-deleted factor VIII ( BDD-FVIII). "
03/01/2015 - "The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison."
02/01/2015 - "Soy phosphatidylinositol containing nanoparticle prolongs hemostatic activity of B-domain deleted factor VIII in hemophilia A mice."
11/01/1995 - "To develop a potential gene therapy strategy for the treatment of hemophilia A, we constructed several retroviral vectors expressing a B-domain-deleted factor VIII (FVIII) cDNA. "
|3.||Pituitary Neoplasms (Pituitary Adenoma)
|1.||7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)
|2.||Complementary DNA (cDNA)
|4.||Factor VIII (Coagulation Factor VIII)